132 Participants Needed

Exercise Training for Atrial Fibrillation

(Exercise-AF Trial)

Recruiting at 1 trial location
JL
MM
Overseen ByMatheus Mistura, MSc
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Ottawa Heart Institute Research Corporation
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how two different exercise programs can help people with atrial fibrillation (a heart condition causing an irregular heartbeat) feel better and improve their exercise capacity. It compares high-intensity interval training (HIIT) and moderate-intensity continuous exercise (MICE) to standard care. The goal is to determine which approach more effectively enhances exercise capacity and quality of life. Individuals with persistent or permanent atrial fibrillation who have a steady heart rate and can perform a symptom-limited exercise test might be suitable candidates for this study. As an unphased trial, this study offers participants a unique opportunity to contribute to understanding how exercise can improve life quality for those with atrial fibrillation.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that these exercise training methods are safe for patients with atrial fibrillation?

Research has shown that both high-intensity interval training (HIIT) and moderate-intensity continuous exercise (MICE) are generally safe for people with atrial fibrillation.

For HIIT, studies have found it effective and safe, with a low risk of serious heart problems. It can enhance heart health, physical fitness, and mental well-being. Some research even suggests HIIT might better reduce atrial fibrillation symptoms and improve quality of life.

MICE has also been shown to lower the risk and symptoms of atrial fibrillation. It improves heart health by reducing inflammation and other risk factors. Studies suggest that regular moderate exercise can lead to fewer heart-related issues over time.

Both types of exercise are well-tolerated by patients, making them good options for improving health in those with atrial fibrillation.12345

Why are researchers excited about this trial?

Researchers are excited about using exercise training for atrial fibrillation because it offers a non-drug approach to managing this heart condition. Unlike standard treatments that often rely on medication or invasive procedures, high-intensity interval training (HIIT) and moderate-intensity continuous exercise training (MICE) focus on improving heart function through physical activity. HIIT pushes the heart with short bursts of intense exercise followed by recovery periods, potentially enhancing cardiovascular fitness more effectively than traditional exercise. MICE, on the other hand, provides a steady, manageable way to improve heart health over longer sessions. These exercise-based strategies could offer patients a more natural way to manage atrial fibrillation with fewer side effects.

What evidence suggests that this trial's exercise training treatments could be effective for atrial fibrillation?

Research has shown that both high-intensity interval training (HIIT) and moderate-intensity continuous exercise (MICE) can benefit people with atrial fibrillation (AF). In this trial, participants will be assigned to different arms to evaluate these exercise methods. The HIIT arm, involving high-intensity interval training, can enhance physical performance, reduce symptoms, and improve quality of life. Some studies suggest it might be even more effective than moderate exercise for these benefits. Meanwhile, the MICE arm, involving moderate-intensity continuous exercise, helps by lowering the risk of AF, reducing symptoms, and improving heart health. Both types of exercise offer more benefits than standard care alone. Overall, exercise training appears promising for managing atrial fibrillation.12367

Who Is on the Research Team?

JL

Jennifer L Reed, PhD

Principal Investigator

Ottawa Heart Institute Research Corporation

Are You a Good Fit for This Trial?

This trial is for adults over 40 with persistent or permanent atrial fibrillation, who can exercise and have a resting heart rate of 100 bpm or less. It's not for those who already exercise regularly, have unstable angina, severe valve disease, obstructive cardiomyopathy, are pregnant or breastfeeding, or can't consent to follow-ups.

Inclusion Criteria

You can do a test that measures your ability to exercise without getting too tired or feeling unwell.
You can do a test where you exercise until you feel symptoms.
I am 40 years old or older.
See 3 more

Exclusion Criteria

I have unstable chest pain.
I have been diagnosed with severe narrowing of my heart's mitral or aortic valve.
I have been diagnosed with a thickened heart muscle that obstructs blood flow.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo high-intensity interval training (HIIT) or moderate-intensity continuous exercise training (MICE) along with standard care

12 weeks
Regular exercise sessions

Follow-up

Participants are monitored for changes in exercise capacity, heart rate control, quality of life, and other health metrics

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • High-Intensity Interval Training
  • Moderate-Intensity Continuous Exercise Training
Trial Overview The study compares the effects of two types of exercise on people with atrial fibrillation: moderate-intensity continuous training (MICE) versus high-intensity interval training (HIIT), in addition to standard care. The focus is on how these exercises affect fitness levels and quality of life.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: standard care + MICEExperimental Treatment1 Intervention
Group II: standard care + HIITExperimental Treatment1 Intervention
Group III: standard careActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ottawa Heart Institute Research Corporation

Lead Sponsor

Trials
200
Recruited
95,800+

Published Research Related to This Trial

A 12-week study involving 94 patients with persistent and permanent atrial fibrillation found that high-intensity interval training (HIIT) was as effective as continuous aerobic training (CR) in improving functional capacity and quality of life.
Both HIIT and CR showed similar outcomes in terms of disease-specific quality of life, resting heart rate, and physical activity levels, indicating that shorter, more intense workouts can be a viable alternative to longer, moderate-intensity training for these patients.
Effect of High-Intensity Interval Training in Patients With Atrial Fibrillation: A Randomized Clinical Trial.Reed, JL., Terada, T., Vidal-Almela, S., et al.[2022]
In a study of 81 heart disease patients with very high cardiovascular risk, both moderate and high-intensity interval training (MIIT and HIIT) were found to be safe, with no adverse outcomes reported during the training.
While there were no statistically significant differences in overall exercise improvements between the training types, the HIIT group showed a trend towards greater improvements in exercise tolerance, suggesting it may be more effective than continuous moderate intensity training (MICT).
Safety and improvement in exercise tolerance with interval training vs moderate-intensity continuous training in heart disease patient of very high cardiovascular risk.Pineda-García, AD., Lara-Vargas, JA., Ku-González, A., et al.[2022]
A scoping review of 69 studies on high-intensity interval training (HIIT) in older adults found that HIIT protocols are generally well-tolerated and can provide significant health benefits, particularly in improving cardiorespiratory fitness.
Most research has focused on healthy older adults, highlighting a need for larger studies and more investigation into HIIT's effects on older adults with various health conditions.
High-Intensity Interval Training in Older Adults: a Scoping Review.Marriott, CFS., Petrella, AFM., Marriott, ECS., et al.[2021]

Citations

Effect of High-Intensity Interval Training in Patients With ...In this randomized clinical trial including 86 individuals with atrial fibrillation, HIIT was as efficacious as MICT in improving functional capacity and ...
Effects of different exercise methods and intensities on the ...High-intensity interval training (HIIT) shows promise, potentially surpassing MICT, especially in reducing age-related AF susceptibility and improving symptoms ...
Does High-Intensity Endurance Training Increase the Risk ...Exercise mitigates many cardiovascular risk factors associated with atrial fibrillation. Endurance training has been associated with atrial structural ...
4.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/36315143/
Effect of High-Intensity Interval Training in Patients With ...High-intensity interval training (HIIT) has been shown to elicit greater improvements in functional capacity and QOL compared with moderate to ...
The Application of High Intensity Interval Training in Atrial ...The findings of these studies reveal promising outcomes related to reduced AF symptoms severity, improved aerobic capacity, quality of life and ...
High‐Intensity Interval Training for Patients With ...HIIT has shown a relatively low rate of major adverse cardiovascular events for patients with coronary artery disease or heart failure when applied within CR ...
Narrative Review of High-Intensity Interval Training: Positive ...This review highlights HIIT as an effective and safe exercise modality for improving CV health, metabolic indicators, mental health, and QoL.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security